Linc00665 activating wnt3a/β-catenin signaling by bond with ybx1 promotes gastric cancer proliferation and metastasis

Linc00665 activating wnt3a/β-catenin signaling by bond with ybx1 promotes gastric cancer proliferation and metastasis

Play all audios:

Loading...

ABSTRACT Long noncoding RNAs (lncRNAs) play a key role in human cancer development; nevertheless, the effect of lncRNA LINC00665 on the progression of gastric cancer (GC) still unclear. In


this study, we found that LINC00665 expression is upregulated in GC than normal gastric mucosa tissues and higher LINC00665 expression is associated with a poor prognosis in GC patients.


Downregulated LINC00665 inhibited GC cells proliferation, invasion, and migration in vitro. Pulmonary metastasis animal models showed that downregulated LINC00665 could reduce the lung


metastasis of GC in vivo. Tumor organoids were generated from human malignant GC tissues, downregulated LINC00665 could inhibit the growth of the organoids of GC tissues. Mechanistically,


downregulated LINC00665 could inhibit GC cells EMT. RNA pulldown, RIP, and RIP-seq studies found that LINC00665 can bind to the transcription factor YBX1 and form a positive feed-forward


loop. The luciferase reporter and CHIP results showed that YBX1 could regulate the transcriptional activity of Wnt3a, and downregulation of LINC00665 could block the activation of


Wnt/β-catenin signaling. In conclusion, our results identified a feedback loop between LINC00665 and YBX1 that activates Wnt/β-catenin signaling, and it may be a potential therapeutic


approach to suppress GC progression. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through


your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant


access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions *


Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS LINC02139 INTERACTS WITH AND STABILIZES XIAP TO REGULATE CELL PROLIFERATION AND APOPTOSIS IN GASTRIC CANCER


Article Open access 12 November 2024 SP-1-ACTIVATED LINC01016 OVEREXPRESSION PROMOTES GASTRIC CANCER INVASION AND METASTASIS THROUGH INHIBITING EIF4A3-MEDIATED MMP9 MRNA DECAY Article Open


access 29 January 2025 ZEB1-INDUCED LINC01559 EXPEDITES CELL PROLIFERATION, MIGRATION AND EMT PROCESS IN GASTRIC CANCER THROUGH RECRUITING IGF2BP2 TO STABILIZE ZEB1 EXPRESSION Article Open


access 06 April 2021 DATA AVAILABILITY All data generated or analyzed during this study are included in this published article and its supplementary information files. The datasets are also


available from the corresponding author on reasonable request. REFERENCES * Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020:


GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49. Article  PubMed  Google Scholar  * Kim H, Hwang Y, Sung H, Jang J,


Ahn C, Kim SG, et al. Effectiveness of gastric cancer screening on gastric cancer incidence and mortality in a community-based prospective cohort. Cancer Res Treat. 2018;50:582–9. Article 


PubMed  Google Scholar  * Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–32. Article  PubMed  Google Scholar  *


Zhang T, Chen H, Yin X, He Q, Man J, Yang X, et al. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: Findings from Global Burden of Disease


Study. Chin J Cancer Res. 2021;33:11–26. Article  CAS  PubMed  PubMed Central  Google Scholar  * Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk


factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21:4012. Article  CAS  PubMed  PubMed Central  Google Scholar  * Cabianca DS, Casa V, Bodega B,


Xynos A, Ginelli E, Tanaka Y, et al. A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell. 2012;149:819–31. Article  CAS 


PubMed  PubMed Central  Google Scholar  * Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, et al. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer.


2020;19:22. Article  CAS  PubMed  PubMed Central  Google Scholar  * Liang ZX, Liu HS, Wang FW, Xiong L, Zhou C, Hu T, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting


with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization. Cell Death Dis. 2019;10:829. Article  PubMed  PubMed Central  Google Scholar  * Wu H, Yang L, Chen LL. The


diversity of long noncoding RNAs and their generation. Trends Genet. 2017;33:540–52. Article  CAS  PubMed  Google Scholar  * Ding J, Zhao J, Huan L, Liu Y, Qiao Y, Wang Z, et al.


Inflammation-induced LINC00665 increases the malignancy through activating PKR/NF-kappaB pathway in hepatocellular carcinoma. Hepatology. 2020;72:1666–81. Article  CAS  PubMed  Google


Scholar  * Liang Y, Song X, Li Y, Chen B, Zhao W, Wang L, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol Cancer. 2020;19:85. Article  CAS 


PubMed  PubMed Central  Google Scholar  * Chang KC, Diermeier SD, Yu AT, Brine LD, Russo S, Bhatia S, et al. MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression.


Nat Commun. 2020;11:6438. Article  CAS  PubMed  PubMed Central  Google Scholar  * Huang C, Leng D, Lei KC, Sun S, Zhang XD. Transcriptome analysis reveals lncRNA-mediated complex regulatory


network response to DNA damage in the liver tissue of Rattus norvegicus. J Cell Physiol. 2019;234:23216–31. Article  CAS  PubMed  Google Scholar  * Ransohoff JD, Wei Y, Khavari PA. The


functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19:143–57. Article  CAS  PubMed  Google Scholar  * Zhang E, He X, Zhang C, Su J, Lu X, Si X, et


al. A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome Biol. 2018;19:154. Article  PubMed  PubMed Central  Google Scholar  * Zhuo W, Liu


Y, Li S, Guo D, Sun Q, Jin J, et al. Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by


competitively binding GMAN-AS. Gastroenterology. 2019;156:676–691.e11. Article  CAS  PubMed  Google Scholar  * Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: from disease code to drug


role. Acta Pharm Sin B. 2021;11:340–54. Article  CAS  PubMed  Google Scholar  * Li H, Ma X, Yang D, Suo Z, Dai R, Liu C. PCAT-1 contributes to cisplatin resistance in gastric cancer through


epigenetically silencing PTEN via recruiting EZH2. J Cell Biochem. 2020;121:1353–61. Article  CAS  PubMed  Google Scholar  * Ji W, Diao Y-L, Qiu Y-R, Ge J, Cao X-C, Yu Y. LINC00665 promotes


breast cancer progression through regulation of the miR-379-5p/LIN28B axis. Cell Death Dis. 2020;11:16. Article  CAS  PubMed  PubMed Central  Google Scholar  * Cong Z, Diao Y, Xu Y, Li X,


Jiang Z, Shao C, et al. Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98. Cell Death Dis.


2019;10:84. Article  PubMed  PubMed Central  Google Scholar  * Guo B, Wu S, Zhu X, Zhang L, Deng J, Li F, et al. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast


cancer progression. EMBO J. 2020;39:e102190. Article  CAS  PubMed  Google Scholar  * Qi H, Xiao Z, Wang Y. Long non-coding RNA LINC00665 gastric cancer tumorigenesis by regulation


miR-149-3p/RNF2 axis. Onco Targets Ther. 2019;12:6981–90. Article  CAS  PubMed  PubMed Central  Google Scholar  * Conlon T, John-Schuster G, Heide D, Pfister D, Lehmann M, Hu Y, et al.


Inhibition of LTβR signalling activates WNT-induced regeneration in lung. Nature. 2020;588:151–6. Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhang Y, Wang X. Targeting the


Wnt/beta-catenin signaling pathway in cancer. J Hematol Oncol. 2020;13:165. Article  PubMed  PubMed Central  Google Scholar  * Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni


N, et al. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation. J Hepatol. 2018;68:1203–13. Article  CAS  PubMed  Google


Scholar  * Yu S, Li L, Cai H, He B, Gao Y, Li Y. Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression. J Exp


Clin Cancer Res. 2021;40:1–16. Article  CAS  Google Scholar  * Wang Z, Li Z, Ji H. Direct targeting of β-catenin in the Wnt signaling pathway: current progress and perspectives. Med Res


Rev. 2021;41:2109–29. Article  CAS  PubMed  PubMed Central  Google Scholar  * Zhai W, Sun Y, Guo C, Hu G, Wang M, Zheng J, et al. LncRNA-SARCC suppresses renal cell carcinoma (RCC)


progression via altering the androgen receptor(AR)/miRNA-143-3p signals. Cell Death Differentiation. 2017;24:1502–17. Article  CAS  PubMed  PubMed Central  Google Scholar  * Wang J, Chen C,


Wang S, Zhang Y, Yin P, Gao Z, et al. Bufalin inhibits HCT116 colon cancer cells and its orthotopic xenograft tumor in mice model through genes related to apoptotic and PTEN/AKT pathways.


Gastroenterol Res Pract. 2015;2015:1–11. Article  Google Scholar  * Wang J, Cai H, Xia Y, Wang S, Xing L, Chen C, et al. Bufalin inhibits gastric cancer invasion and metastasis by


down-regulating Wnt/ASCL2 expression. Oncotarget. 2018;9:23320–33. Article  PubMed  PubMed Central  Google Scholar  * Li W, Wong CC, Zhang X, Kang W, Nakatsu G, Zhao Q, et al. CAB39L


elicited an anti-Warburg effect via a LKB1-AMPK-PGC1alpha axis to inhibit gastric tumorigenesis. Oncogene. 2018;37:6383–98. Article  CAS  PubMed  PubMed Central  Google Scholar  * Simion V,


Zhou H, Haemmig S, Pierce JB, Mendes S, Tesmenitsky Y, et al. A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. Nat Commun. 2020;11:6135.


Article  CAS  PubMed  PubMed Central  Google Scholar  * Wang X, Li L, Zhao K, Lin Q, Li H, Xue X, et al. A novel LncRNA HITT forms a regulatory loop with HIF-1alpha to modulate angiogenesis


and tumor growth. Cell Death Differ. 2020;27:1431–46. Article  CAS  PubMed  Google Scholar  * Seidlitz T, Merker SR, Rothe A, Zakrzewski F, von Neubeck C, Grützmann K, et al. Human gastric


cancer modelling using organoids. Gut. 2019;68:207–17. Article  CAS  PubMed  Google Scholar  * Wang CY, Colognori D, Sunwoo H, Wang D, Lee JT. PRC1 collaborates with SMCHD1 to fold the


X-chromosome and spread Xist RNA between chromosome compartments. Nat Commun. 2019;10:2950. Article  PubMed  PubMed Central  Google Scholar  * Yuan L, Xu ZY, Ruan SM, Mo S, Qin JJ, Cheng XD.


Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance. Mol Cancer. 2020;19:96. Article  CAS  PubMed  PubMed Central  Google


Scholar  * Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X, et al. CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther.


2020;5:298. Article  CAS  PubMed  PubMed Central  Google Scholar  * Feng M, Xie X, Han G, Zhang T, Li Y, Li Y, et al. YBX1 is required for maintaining myeloid leukemia cell survival by


regulating BCL2 stability in an m6A-dependent manner. Blood. 2021;138:71–85. Article  CAS  PubMed  PubMed Central  Google Scholar  * Lin Y, Zhang J, Li Y, Guo W, Chen L, Chen M, et al. CTPS1


promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. J Transl Med. 2022;20:17. Article  CAS  PubMed  PubMed Central  Google Scholar  *


Shi C, Yang Y, Yu J, Meng F, Zhang T, Gao Y. The long noncoding RNA LINC00473, a target of microRNA 34a, promotes tumorigenesis by inhibiting ILF2 degradation in cervical cancer. Am J Cancer


Res. 2017;7:2157–68. CAS  PubMed  PubMed Central  Google Scholar  * Zhang X, Wu J. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-beta pathway in


gastric cancer. Pathol Res Pract. 2021;224:153492. Article  CAS  PubMed  Google Scholar  * Yang B, Bai Q, Chen H, Su K, Gao C. LINC00665 induces gastric cancer progression through activating


Wnt signaling pathway. J Cell Biochem. 2020;121:2268–76. Article  CAS  PubMed  Google Scholar  * Conlon GA, Murray GI. Recent advances in understanding the roles of matrix


metalloproteinases in tumour invasion and metastasis. J Pathol. 2019;247:629–40. Article  PubMed  Google Scholar  * Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev


Pathol. 2018;13:395–412. Article  CAS  PubMed  Google Scholar  * Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461–73. Article  CAS  PubMed  Google Scholar  *


Ma Y, Yang Y, Wang F, Moyer M, Wei Q, Zhang P, et al. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/β-catenin signalling pathway via suppression of


activator protein 2α. Gut. 2016;65:1494–504. Article  CAS  PubMed  Google Scholar  * Wang H, Wu M, Lu Y, He K, Cai X, Yu X, et al. LncRNA MIR4435-2HG targets desmoplakin and promotes growth


and metastasis of gastric cancer by activating Wnt/β-catenin signaling. Aging. 2019;11:6657–73. Article  CAS  PubMed  PubMed Central  Google Scholar  * MacDonald BT, Tamai K, He X.


Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26. Article  CAS  PubMed  PubMed Central  Google Scholar  * Mo D, Fang H, Niu K, Liu J, Wu M, Li S, et


al. Human helicase RECQL4 drives cisplatin resistance in gastric cancer by activating an AKT-YB1-MDR1 signaling pathway. Cancer Res. 2016;76:3057–66. Article  CAS  PubMed  Google Scholar  *


Wu Y, Yamada S, Izumi H, Li Z, Shimajiri S, Wang KY, et al. Strong YB-1 expression is associated with liver metastasis progression and predicts shorter disease-free survival in advanced


gastric cancer. J Surg Oncol. 2012;105:724–30. Article  CAS  PubMed  Google Scholar  * Byrne AT, Alferez DG, Amant F, Annibali D, Arribas J, Biankin AV, et al. Interrogating open issues in


cancer precision medicine with patient-derived xenografts. Nat Rev Cancer. 2017;17:254–68. Article  CAS  PubMed  Google Scholar  * Steele NG, Chakrabarti J, Wang J, Biesiada J, Holokai L,


Chang J, et al. An organoid-based preclinical model of human gastric cancer. Cell Mol Gastroenterol Hepatol. 2019;7:161–84. Article  PubMed  Google Scholar  * Sato T, Stange DE, Ferrante M,


Vries RG, Van Es JH, Van den Brink S, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology.


2011;141:1762–72. Article  CAS  PubMed  Google Scholar  * Dekkers JF, van Vliet EJ, Sachs N, Rosenbluth JM, Kopper O, Rebel HG, et al. Long-term culture, genetic manipulation and


xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021;16:1936–65. Article  CAS  PubMed  PubMed Central  Google Scholar  * Bleijs M, van de Wetering M, Clevers H,


Drost J. Xenograft and organoid model systems in cancer research. EMBO J. 2019;38:e101654. Article  PubMed  PubMed Central  Google Scholar  Download references ACKNOWLEDGEMENTS We


acknowledge the GEO and TCGA databases, Kaplan–Meier Plotter database for providing their platforms and contributors for uploading their meaningful datasets. FUNDING This work was supported


by the National Nature Science Foundation of China (81973625), the foundation of National Key Research and Development Program of China (2019YFC1316000), the foundation of Shanghai key


medical specialty construction project (ZK2019B18), the foundation of within the budget of Shanghai University of Traditional Chinese Medicine (2019LK037), and the foundation of clinical


specialized disease Construction Project of Shanghai Putuo District Municipal Health Comission (2019tszb01). AUTHOR INFORMATION Author notes * These authors contributed equally: Jie Wang,


Dongxiao Shen, Shichao Li. AUTHORS AND AFFILIATIONS * Department Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, 200062, Shanghai, China Jie Wang, Dongxiao


Shen, Qingsong Zuo, Peihao Yin, Chao Chen & Teng Chen * Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese


Medicine, 200062, Shanghai, China Jie Wang, Qiuying Li, Peihao Yin, Chao Chen & Teng Chen * Shanghai Putuo Central School of Clinical Medicine, Anhui Medical University, 230022, Anhui,


China Jie Wang, Jiahao Lu, Donghao Tang, Yuejiao Feng, Peihao Yin, Chao Chen & Teng Chen * The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, 646000,


Luzhou, China Shichao Li Authors * Jie Wang View author publications You can also search for this author inPubMed Google Scholar * Dongxiao Shen View author publications You can also search


for this author inPubMed Google Scholar * Shichao Li View author publications You can also search for this author inPubMed Google Scholar * Qiuying Li View author publications You can also


search for this author inPubMed Google Scholar * Qingsong Zuo View author publications You can also search for this author inPubMed Google Scholar * Jiahao Lu View author publications You


can also search for this author inPubMed Google Scholar * Donghao Tang View author publications You can also search for this author inPubMed Google Scholar * Yuejiao Feng View author


publications You can also search for this author inPubMed Google Scholar * Peihao Yin View author publications You can also search for this author inPubMed Google Scholar * Chao Chen View


author publications You can also search for this author inPubMed Google Scholar * Teng Chen View author publications You can also search for this author inPubMed Google Scholar CONTRIBUTIONS


TC and CC conceived or designed the experiments; JW, DXS, and CSL performed the experiments and write the manuscript; QYL performed part of the animal experiments; JHL, DHT, and YJF


performed part of the cell and molecular and biology experiments; QSZ and PHY performed part of the clinical patients collect and data analysis. All authors read and approved the final


manuscript. CORRESPONDING AUTHORS Correspondence to Chao Chen or Teng Chen. ETHICS DECLARATIONS COMPETING INTERESTS The authors declare no competing interests. ETHICAL APPROVAL Human samples


used in this study was obtained with informed consent and was approved by the Ethics Committee of Putuo Hospital, Shanghai University of Traditional Chinese Medicine (PTEC-A-2020-5(S)-1).


All the animal studies were performed strictly in accordance with the Animal Care Guidelines approved by the Animal Care Committee of East China Normal University. ADDITIONAL INFORMATION


PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. SUPPLEMENTARY INFORMATION SUPPLEMENTARY FILE


SUPPLEMENTARY FIGURE S1 SUPPLEMENTARY FIGURE S2 SUPPLEMENTARY FIGURE S3 RIGHTS AND PERMISSIONS Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to


this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the


terms of such publishing agreement and applicable law. Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Wang, J., Shen, D., Li, S. _et al._ LINC00665 activating Wnt3a/β-catenin


signaling by bond with YBX1 promotes gastric cancer proliferation and metastasis. _Cancer Gene Ther_ 30, 1530–1542 (2023). https://doi.org/10.1038/s41417-023-00657-4 Download citation *


Received: 02 May 2023 * Revised: 16 July 2023 * Accepted: 01 August 2023 * Published: 10 August 2023 * Issue Date: November 2023 * DOI: https://doi.org/10.1038/s41417-023-00657-4 SHARE THIS


ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard


Provided by the Springer Nature SharedIt content-sharing initiative